VXRT - Vaxart or Inovio: Which Is More Likely to Double Your Money?
There are many ways to examine a stock's potential. For biotech companies, I usually look at their pipelines, revenue prospects, and various financial metrics. But today, I'm going to look at something different: what other investors say about two particular stocks. And the best way to do this is by playing a game called Motley Fool CAPS . This stock-picking game uses the wisdom of crowds to find great investments.
Here's how it works. Players predict which stocks will outperform or underperform the S&P 500 over a particular time frame. Then, CAPS rates these players on their accuracy compared to other players. It also rates each stock according to the number of players who say it will beat the S&P 500. A key point: The game gives greater weight to the opinions of the more highly rated players. So let's use Motley Fool CAPS to take a look at Vaxart (NASDAQ: VXRT) and Inovio Pharmaceuticals (NASDAQ: INO) -- two coronavirus vaccine stocks that soared by more than 1,000% and 168%, respectively, last year.
Image source: Getty Images.
For further details see:
Vaxart or Inovio: Which Is More Likely to Double Your Money?